levofloxacin has been researched along with 2-acetylaminofluorene in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (2-acetylaminofluorene) | Trials (2-acetylaminofluorene) | Recent Studies (post-2010) (2-acetylaminofluorene) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 2,352 | 0 | 97 |
| Protein | Taxonomy | levofloxacin (IC50) | 2-acetylaminofluorene (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.143 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.016 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 8.595 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.059 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 8.595 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.143 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 6.053 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
1 other study(ies) available for levofloxacin and 2-acetylaminofluorene
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |